The results observed in the present study suggest, that NAT2 genotype has a trend of association for prostate cancer risk when considered alone (OR = 1.452, 95% CI: 0.54–1.87, P = 0.136) but is statistically non-significant (Table 2). The gene discussed is NAT2; the disease is prostate carcinoma.